Aptalis

Global specialty pharmaceutical company
Leader in gastrointestinal and cystic fibrosis therapies*

Aptalis to be Acquired by Forest Laboratories for $2.9 Billion

Back To News

Subscribe to the TPG Healthcare Newsletter

First*

Last*

Email*

Thank you!

Information provided above will be used by a third-party platform for distributing the newsletter. You can unsubscribe at any time via the link in the footer of the newsletter.

Explore TPG
Connect With Us
- media@tpg.com
- InvestorRelations@tpg.com
Limited Partner Login
Our Offices

Twitter
LinkedIn

This site uses cookies that are essential for our site to work. We would also like to use non-essential cookies to help us improve your browsing experience and help make this website better, by collecting and reporting information on how you use our site. For more information about the cookies we use please read our PRIVACY POLICY

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Withdraw Consent

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.